Abstract

Dr. Anna Kirby is the ESTRO President-Elect and a Consultant Clinical Oncologist working at the Royal Marsden and Institute of Cancer Research, UK. Dr. Kirby graduated from Cambridge University in 1995 with a first-class honors degree in Medicine and Psychology. She completed her oncology training at The Royal Marsden and Guy’s and St Thomas’ Hospitals followed by a research degree at the Institute of Cancer Research. She specializes in the treatment of patients with breast cancer and leads research into novel breast radiotherapy techniques. She is Chief Investigator of the UK HeartSpare and HeartSpare Plus studies, and breast Lead Investigator on the UK CORE trial evaluating the role of stereotactic radiotherapy in treating metastatic disease.

Continue reading the interview HERE